What is needed to get Australians vaccinated by December? Completing the vaccination program in 2021 is plausible, but GPs say additional funding and delivering mRNA vaccines will be crucial to utilising general practice’s ‘untapped capacity’.
Mounting evidence suggests COVID vaccines do reduce transmission Since vaccines began rolling out across the world, many scientists have been hesitant to say they can reduce transmission of the virus.
Promise wanes for mRNA onshore production With local manufacturing of mRNA vaccines looking increasingly slim in the short term, where does that leave Australia?
No evidence that recent blood clot deaths were linked to COVID vaccine The TGA has confirmed there is ‘no likely association’ between the deaths of two NSW men and the AstraZeneca vaccine.
Numbers confirm GPs are the ‘backbone’ of COVID vaccine rollout Australia’s GPs have now administered more than 1.05 million vaccine doses – more than half the rollout’s total of 2.03 million.
Benefits of AstraZeneca overwhelmingly high despite increased clotting risk New European research has found the risk of a rare blood clotting syndrome associated with the vaccine is double what has been previously reported.
The world wants mRNA vaccines – but we’re short of vital components Given AstraZeneca is no longer recommended for under-50s, Australia is looking to other vaccines to fill the gap.
Are blood clots a concern with mRNA vaccines? An investigation into Australia’s first case of blood clotting after the Pfizer vaccine has yet to confirm a link.
Funding for in-home COVID vaccine assessments ‘inadequate’ GPs have questioned the lack of a dedicated MBS item number for housebound patients.
What would it take for Australia to manufacture mRNA vaccines? Experts say investing in RNA technology now will help to protect Australia, and its neighbours, beyond the current pandemic.